Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
40.46
-1.25 (-3.00%)
May 7, 2026, 12:06 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Product Net Revenue
5.42M-
Collaboration and License Revenue
2.28M1.04M
Collaboration and License Revenue Growth
119.06%-74.11%
Revenue (Total)
7.70M1.04M
Revenue (Total) Growth
640.71%-74.11%
Updated Feb 26, 2026. Data Source: Fiscal.ai.